GNFT Soars On LabCorp Deal, INO's COVID-19 Vaccine Trial On Partial Hold, FDA Expands Xeljanz Label

Today's Daily Dose brings you news about Abeaona's leadership and Board transitions, GENFIT's deal with LabCorp., FDA hold on Inovio's planned Phase 2/3 Covid-19 vaccine trial, the new CEO of Merck KGaA, and label expansion of Pfizer's blockbuster drug Xeljanz.